- Text-only version of this website
- Skip navigation
- Home page
- What's new
- Contact Webmaster
- Website policies
- Disability services
The study, partially funded by a UF College of Pharmacy PROSPER award, was published in Pharmacoeconomics Open.
Wei, Ph.D., an assistant professor of pharmaceutical outcomes and policy, shares the advice she’d give to her younger self in this video produced for the Today Show online.
The article titled, “Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD,” was selected for an editorial highlight by the journal which has an impact factor of 13.25.
The pair were among eight students who competed in the oral competition at the UF College of Pharmacy’s annual event.
Diaby’s team used a decision analytic model to simulate and compare the cost and effectiveness associated with treatment strategies.
UF College of Pharmacy researchers studied performance-based risk-sharing agreements in Europe and the United States to identify opportunities to reduce drug costs for patients.